Trial Profile
Everolimus Before Cytomegalovirus Infection to Prevent CMV Recurrence in Heart Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ganciclovir
- Indications Cytomegalovirus infections; Heart transplant rejection
- Focus Therapeutic Use
- 20 Aug 2015 New trial record